New insights into type I interferon and the immunopathogenesis of persistent viral infections

被引:38
|
作者
Snell, Laura M. [1 ,2 ]
Brooks, David G. [1 ,2 ,3 ,4 ]
机构
[1] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, David Geffen Sch Med, Los Angeles, CA 90095 USA
[2] Univ Calif Los Angeles, David Geffen Sch Med, UCLA AIDS Inst, Los Angeles, CA 90095 USA
[3] Univ Toronto, Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada
[4] Univ Toronto, Dept Immunol, Toronto, ON M5G 2M9, Canada
基金
美国国家卫生研究院;
关键词
CHRONIC HEPATITIS-C; CD8; T-CELLS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; PLASMACYTOID DENDRITIC CELLS; FOLLICULAR HELPER; IMMUNE ACTIVATION; CLONAL EXPANSION; HIV; EXPRESSION; RESPONSES;
D O I
10.1016/j.coi.2015.03.002
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Most viruses generate potent T cell responses that rapidly control infection. However, certain viruses can subvert the immune response to establish persistent infections. The inability to clear virus induces an immunosuppressive program leading to the sustained expression of many immunoregulatory molecules that down-regulate T cell responses. Further, viral persistence is associated with multiple immune dysfunctions including lymphoid disorganization, defective antigen presentation, aberrant B cell responses and hypergammaglobulinemia. Although best known for its antiviral activity, recent data has highlighted the role of type I IFN (IFN-I) signaling as a central mediator of immunosuppression during viral persistence. It is also becoming increasingly apparent that many of the immune dysfunctions during persistent virus infection can be attributed directly or indirectly to the effects of chronic IFN-I signaling. This review explores the increasingly complex role of IFN-I in the regulation of immunity against persistently replicating virus infections and examines current and potential uses of IFN-I and blockade of IFN-I signaling to dampen chronic inflammation and activation in the clinic.
引用
收藏
页码:91 / 98
页数:8
相关论文
共 50 条
  • [41] The role of regulatory T cells in immunopathogenesis and immunotherapy of viral infections
    Karkhah, Ahmad
    Javanian, Mostafa
    Ebrahimpour, Soheil
    INFECTION GENETICS AND EVOLUTION, 2018, 59 : 32 - 37
  • [42] New insights into the immunopathogenesis of celiac disease
    Dreier, G
    Stüber, E
    Koop, I
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 1999, 37 (01): : 117 - 119
  • [43] Type I interferon-induced β-catenin promotes hematopoietic stem cell activation in persistent viral infection in mice
    Nguyen, Trieu Hai
    Kwarteng, Edward
    Laulhe, Xavier
    Chartrand, Karine
    Lamarre, Alain
    Heinonen, Krista
    JOURNAL OF IMMUNOLOGY, 2021, 206
  • [44] Neurons produce type I interferon during viral encephalitis
    Delhaye, Sophie
    Paul, Sophie
    Blakqori, Gjon
    Minet, Muriel
    Weber, Friedemann
    Staeheli, Peter
    Michiels, Thomas
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (20) : 7835 - 7840
  • [45] Recent advances in understanding viral evasion of type I interferon
    Taylor, Kathryne E.
    Mossman, Karen L.
    IMMUNOLOGY, 2013, 138 (03) : 190 - 197
  • [46] Vasculitis and chronic persistent viral infections
    Calabrese, LH
    ANNALES DE MEDECINE INTERNE, 1998, 149 (07): : 395 - 397
  • [47] Common Threads in Persistent Viral Infections
    Kane, Melissa
    Golovkina, Tatyana
    JOURNAL OF VIROLOGY, 2010, 84 (09) : 4116 - 4123
  • [48] New interferon inducing and producing preparation in treatment of viral and bacterial infections
    Timofeyev, I
    Paletskaya, T
    Perminova, N
    Nozdrin, G
    Lelyak, A
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 537 - 537
  • [49] IMMUNOPATHOLOGY OF PERSISTENT VIRAL-INFECTIONS
    OLDSTONE, MBA
    HOSPITAL PRACTICE, 1982, 17 (12): : 61 - 72
  • [50] IMMUNOTHERAPY OF PERSISTENT VIRAL-INFECTIONS
    SHANLEY, JD
    STANBERRY, LR
    REVIEWS IN MEDICAL VIROLOGY, 1994, 4 (02) : 105 - 118